Our leadership is deeply embedded in the industry and supported by an Advisory Board of experts from every sector that we serve.
Staying at the cutting edge of every change in the market allows us to deliver the right candidates for your business and provide invaluable counsel no matter how unique your needs.
Founded in 2000, Slone Partners is a premier executive search firm that specializes in recruitment for companies focused in biotechnology, pharma services, life science tools, diagnostics, genomics, clinical services, medical devices, data and analytics, and food sciences.
Executive search firm Slone Partners has placed Dr. Michael Dugan as chief medical officer of Clinical Genomics. Dr. Dugan is a well known biotechnology leader with extensive clinical experience in both commercial and academic settings. In his new role, Dr. Dugan will lead medical affairs and clinical trials, develop key opinion leader relationships, and build a scientific advisory board.
Executive search firm Slone Partners has placed Matthew Watson as the new chief executive officer of Westox Labs. In his new role, Mr. Watson will lead and oversee all aspects of the business, including sales, marketing, operations, finance, billing, and compliance. With over 25 years of experience, Mr. Watson is a veteran healthcare executive and entrepreneur who has
Executive search firm Slone Partners has named Leslie Loveless as its new chief executive officer. She succeeds Adam Slone, who founded the firm in 2000. Mr. Slone will remain engaged with the firm, focusing specifically on strategy, finance, mergers and acquisitions, advisement and business development in Boston and California. Ms. Loveless joined Slone Partners in 2007
Executive recruiters Slone Partners has placed Dr. Richard Bender as chief medical officer at Signal Genetics, a commercial stage, molecular genetics diagnostic company located in Little Rock, AR. Dr. Bender has spent 25 years in clinical practice the majority spent serving as the medical director for oncology / hematology for Kaiser Permanente in San Diego. In 2002 he
Thought Leadership
Elevating Executive Presence: A Blueprint for Life Sciences and Biotech Leaders
What’s Next in Precision Medicine: Leadership Challenges and Opportunities
Full-Time vs. Fractional Talent: What’s the Best Fit for Your Organization?
Fractional Talent On Demand: The Slone Partners Difference
Life Sciences Leadership, Redefined: What Boards are Looking for in 2025